This page lists investors from the Cut Through Venture investor database that back Australian biotech, medtech and life sciences companies, including specialist life science funds, university-linked investors and generalist VCs with a healthcare practice.
Biotech and medtech is Australia's deepest research-driven sector. It ranked third by capital in 2025 with $829M and led every sector on deal count with 49 deals, according to the State of Australian Startup Funding 2025. Victoria is the national hub, with biotech and medtech raising $526M there in 2025 per the Victoria Venture Capital Report 2025. Median rounds in life sciences tend to be smaller and earlier than the market average.
Filter by stage to find funds with the right mandate, and read the latest reports for sector benchmarks.